ECEnteric coatedUnder development — not offered for commercial distribution
Dexlansoprazole Delayed Dual Release Pellets
Active ingredient Dexlansoprazole
Dual delayed-release multiparticulate technology in development pipeline.
Supply form: semi-finished, ready-to-fill pellets. Not for direct patient dispensing.
Formulation and monograph
- Potency / drug load
- 20.0% & 22.5% w/w
- Validated strengths
- 20.0%, 22.5% w/w
- Pharmacopoeia
- In-house Development Specification monograph
Packaging and storage
- Primary moisture barrier: double virgin polyethylene liners, heat-sealed, with pharmaceutical-grade silica gel desiccants.
- Secondary pack: tamper-evident HDPE drums suitable for domestic transport or export freight.
- Store protected from direct sunlight and humidity, at the temperature specified by the active-substance monograph.
